PMC:7307149 / 21119-21447 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T142","span":{"begin":54,"end":57},"obj":"Body_part"},{"id":"T143","span":{"begin":99,"end":102},"obj":"Body_part"}],"attributes":[{"id":"A142","pred":"fma_id","subj":"T142","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A143","pred":"fma_id","subj":"T143","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T93","span":{"begin":115,"end":123},"obj":"Disease"}],"attributes":[{"id":"A93","pred":"mondo_id","subj":"T93","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T211","span":{"begin":58,"end":65},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T212","span":{"begin":124,"end":131},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T213","span":{"begin":182,"end":183},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations."}

{"project":"LitCovid-PubTator","denotations":[{"id":"383","span":{"begin":115,"end":123},"obj":"Disease"}],"attributes":[{"id":"A383","pred":"tao:has_database_id","subj":"383","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations."}

{"project":"LitCovid-sentences","denotations":[{"id":"T113","span":{"begin":0,"end":328},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, we do at this juncture recommend integrating HLA testing into clinical trials and pairing HLA typing with COVID-19 testing where feasible to more rapidly develop and deploy a predictor(s) of viral severity in the population and, potentially, to tailor future vaccination strategies to genotypically at-risk populations."}